Figure 3
Figure 3. Analysis of platelet FVIII expression in 2bF8LV-transduced xenotransplanted recipients. Platelets were lysed in 0.5% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS). The levels of platelet-derived FVIII expression were determined by chromogenic FVIII activity (FVIII:C) assay of platelet lysates from recipients at least 3 weeks after transplantation. Bars represent mean ± SD. The average FVIII level was calculated for individual mice analyzed more than once over the course of study. Platelets from NSG mice, C57BL/6 mice, and normal human individuals were used as controls. (A) Quantitative evaluation of FVIII activity levels in platelet lysates from 2bF8LV-transduced hCBT NSG or NSGF8KO recipients. (B) Quantitative evaluation of FVIII activity levels in hCB-derived human platelets based on human platelet numbers as determined by flow cytometry. Data are summarized from 10 trials of xenotransplants. NA, not applicable.

Analysis of platelet FVIII expression in 2bF8LV-transduced xenotransplanted recipients. Platelets were lysed in 0.5% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS). The levels of platelet-derived FVIII expression were determined by chromogenic FVIII activity (FVIII:C) assay of platelet lysates from recipients at least 3 weeks after transplantation. Bars represent mean ± SD. The average FVIII level was calculated for individual mice analyzed more than once over the course of study. Platelets from NSG mice, C57BL/6 mice, and normal human individuals were used as controls. (A) Quantitative evaluation of FVIII activity levels in platelet lysates from 2bF8LV-transduced hCBT NSG or NSGF8KO recipients. (B) Quantitative evaluation of FVIII activity levels in hCB-derived human platelets based on human platelet numbers as determined by flow cytometry. Data are summarized from 10 trials of xenotransplants. NA, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal